2023 UN contributions on Human rights and drug policy
We sent 2 contribution for the upcoming UN Human Rights report on drug policies – due diligence, herbal drugs, traditional use, homegrowing
Lex lata cannabis legalization: statement at the 2022 United Nations Commission on Narcotic Drugs
[Video] Plenary statement at the 65th UN Commission on Narcotic Drugs, about a cannabis legalization compliant with the drug conventions
Press release — INCB Cannabis Initiative: NGOs from 56 countries call for transparency & accountability
2 Dec. 2021 – 181 NGOs from 56 Countries call upon INCB drugs agency to create transparency and accountability in ‘Cannabis Initiative’ Guidelines effort
History, science, and politics of international cannabis scheduling, 2015–2021
Just published: Oct. 2021 report on the 2015-2021 cannabis scheduling process at the WHO and United Nations (open access PDF)
Press release — History made today: UN recognizes medical cannabis
After 60 years of status quo, 3 years of scientific review by WHO and 2 years of diplomatic discussions, today, the United Nations finally withdrew cannabis from 1961 Convention Schedule IV –the «prohibition schedule»
WHO cannabis vote: Support patient access to medicine, vote yes! [signed by 193 NGOs]
194 organizations from 50 countries call for Cannabis deschedulling at the United Nations in official statement.
A call for UN to monitor medical cannabis patients’ rights
Ensuring continuity of treatment during the COVID-19 pandemic for patients using Cannabis and cannabinoid medicines.
Monitoring the votes on Cannabis scheduling changes
United Nations ECOSOC makes public the list of voters on WHO Cannabis Scheduling recommendations.
Declaración de Berlín
Declaración de Berlín | Hacia un Modelo Humano de Políticas de Drogas
Breaking news: WHO changes position on medical Cannabis after 60 years.
PRESS RELEASE | 31st Jan. 2019 | Outcome of #ECDD41 on Cannabis. World Health Organization acknowledges medical use of Cannabis after 60 years of denial.
Press statement – WHO Cannabis Review non-outcome
ECDD41: WHO finishes this week its historic review of Cannabis
WHO finishes this week their scientific review of cannabis, THC, CBD extracts, etc. Their conclusions could change cannabis scheduling in the drug Treaties.
Youth NGOs make their views heard on Global Drug Policy
Ahead of a Global Drug Summit in March 2019, a coalition of youth organizations address the governments of the planet: «Make drug policies with us, not on our name and against us!»
INCB: a decade of evolutions and progress
International Cannabis Policy Conference | Vienna 2018
FAAAT launches the International Cannabis Policy Conference | Vienna, Austria | December 7-9, 2018 | #CannabiSDG | www.cannabis-conference.com
Cannabis: WHO just acknowledged historical misjudgment and heads towards global policy update
After thoroughly assessing Cannabis, THC and CBD in June, the WHO has just recognized its historical misjudgment that led to the placement of Cannabis medicines among heroin or fentanyl derivates, and will consider an international change of scheduling to adequate policies with evidence. #ECDD40
DUPLICATA POST — 40º Comité de Drogodependencia de la OMS: momento crucial para las políticas globales del Cannabis.
Por primera vez en la historia, el Comité sobre drogas de la OMS ha escuchado las voces de los médicos, pacientes e investigadores, y comenzó un proceso neutral de evaluación de los daños y beneficios del Cannabis.
Comunicado de prensa: OMS y Cannabis – 40º Comité de Expertos ECDD
COMUNICADO DE PRENSA • Políticas del Cannabis: Activistas de todos continentes convergen en Ginebra – Día histórico en la Organizacion Mundial de la Salud.
Human Rights violations in the name of Drug Control: contribution to UN Human Rights
57 years of Global and Systematic Human Rights violations in the name of #DrugControl: Right to a Remedy and Reparation for Victims of Gross Violations of International Human Rights Law.
Crimson paper #3. The review(s).
Pre & Critical reviews: insights into the processes of the WHO scientific abuse liability assessment for drugs.
Major shift in global drug policies: the Human Rights Council catches up with the Commission on Narcotic Drugs
Last month, the main UN body on drugs self-disqualified, leaving room for UN Human Rights organs to increase influence over global drug policies.
[VIDEO] Jerarquía de normas: Derechos humanos vs. fiscalización de drogas. #LegalRegulations
#LegalRegulations • ¿Los Convenios de drogas de verdad prohiben regular? Lo hemos reguntado a 3 expertos clave: ¿Es posible una legalización?
After UNGASS: the Way Forward for UN Drug Strategies
Statement delivered to the 6th Intersessional meeting of the UN Commission on Narcotic Drugs, about the «way forward and preparations for the 62nd session of the CND in 2019» on November 16th, 2017.
A crowdfunding to support our action at WHO
Crimson paper #2. The committee.
The crimson papers are a series of short documents aimed at sharing knowledge regarding the process of scheduling plants, medicines and substances within the international drug control treaty framework.
Crimson paper #1. Las listas.
Los crimson papers son una serie de documentos cortos, en ingles, que comparten conocimiento sobre el proceso de clasificación de plantas, fármacos y sustancias bajo el marco internacional de fiscalización de drogas.
Tidbits from the United Nations lobbies, 60th Commission on Narcotic Drugs
Four simple questions about present and future drug policies were asked to stakeholders attending the 60th UN Commission on Narcotic Drugs. Their answers in videos.
After UNGASS 2016, let’s release hemp to achieve the SDGs
Reassessing substances: a proposed reading of the UNGASS 2016 outcome document
FAAAT submitted a contribution to the post-UNGASS 2016 thematic debates organized by the UN Commission on Narcotic Drugs, on October 2016. This contribution has been posted online on the website of the UNODC and can be downloaded here.
Actions à la 69ème Assemblée Mondiale de la Santé
Résumé des actions du do-tank FAAAT à la 69ème Assemblée Mondiale de la Santé à Genève, du 23 au 28 mai 2016.
Towards an evidence-based approach to drug policies : the Critical review of Cannabis
Conferencia « Introducción al Cannabis Social Club » en las NN.UU
Cannabis Social Club : un modelo social, ético, basado en la salud y a tamaño humano tanto para combatir el mal uso, abuso y los daños potenciales debidos al consumo de cannabis como para luchar contra el crecimiento desregulado del suministro de cannabis.
UNGASS 2016 : Declaración común de la sociedad civil.
Cannabis Social Club • Una política para el siglo XXI
Cannabis Social Club : un modèle social, éthique, à échelle humaine et aux bases sanitaires pour faire face au mésusage, à l’abus et aux dommages potentiels liés à l’usage de cannabis, tout en combattant la croissance dérégulée de l’offre.
Folio Temático #1 • Dosis de refuerzo de historia política internacional de las drogas.
This first document of the series of Thematic Papers provides initial paths for comprehension of the political history of the international drug control system, which only managed to cause the opposite effects to its purposes.
